Download Files:
LUF6283
SKU
HY-100976-5 mg
Category Reference compound
Tags GPCR/G Protein, Hydroxycarboxylic Acid Receptor (HCAR), Metabolic Disease
$250
Only 1000 item(s) left in stock.
Products Details
Product Description
– LUF6283 is a potent and orally active HCA(2) partial agonist, with a Ki of 0.55 µM. LUF6283 can achieve the beneficial lipid lowering effect of niacin without producing the unwanted cutaneous flushing side effect[1].
Web ID
– HY-100976
Storage Temperature
– -20°C (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C8H12N2O2
References
– [1]Li Z, et al. Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice. Br J Pharmacol. 2012 Oct;167(4):818-25.
CAS Number
– 92933-48-7
Molecular Weight
– 168.19
Compound Purity
– 99.0
SMILES
– O=C(C1=NNC(CCCC)=C1)O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Hydroxycarboxylic Acid Receptor (HCAR)
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.